Enanta Pharmaceuticals, Inc. ( ENTA) - Key Metrics
ENTA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | $0.65 | -$0.42 | -$0.41 | -$0.41 |
| 2025Q4 | $0.71 | -$0.87 | -$0.30 | -$0.37 |
| 2025Q3 | $0.86 | -$0.86 | $0.82 | $0.81 |
| 2025Q2 | $0.70 | -$1.06 | -$0.63 | -$0.75 |
ENTA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | -9.49 |
| 2025Q4 | ? | -3.42 |
| 2025Q3 | ? | -2.21 |
| 2025Q2 | ? | -1.30 |
ENTA
Price: $12.07
52 week price:
Earnings Per Share: -2.60 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3045
Ebitda: 15.9 millionMarket Capitalization: 272.3 million